(Q42633382)

4 November 2017

The inhibitors of nucleotide biosynthesis leflunomide, FK778, and mycophenolic acid activate hepatitis B virus replication in vitro (English)

1 reference

4 November 2017

1 reference

4

Felix Hoppe-Seyler

1 reference

4 November 2017

1

Karin Hoppe-Seyler

1 reference

4 November 2017

3

Claudia Lohrey

1 reference

4 November 2017

2

Peter Sauer

1 reference

PubMed ID

22271223

4 November 2017

language of work or name

English

0 references

publication date

1 June 2012

1 reference

4 November 2017

1 reference

4 November 2017

56

1 reference

4 November 2017

1

1 reference

4 November 2017

9-16

1 reference

Leflunomide: a drug with a potential beyond rheumatology

4 November 2017

1 reference

Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide

21 January 2018

1 reference

Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system

21 January 2018

1 reference

Leflunomide for polyomavirus type BK nephropathy

21 January 2018

1 reference

Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide.

21 January 2018

1 reference

FK778 attenuates cytomegalovirus-enhanced vein graft intimal hyperplasia in a rat model.

21 January 2018

1 reference

Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide

21 January 2018

1 reference

Anti-HIV-1 activity of leflunomide: a comparison with mycophenolic acid and hydroxyurea

21 January 2018

1 reference

Inhibition of respiratory syncytial virus in vitro and in vivo by the immunosuppressive agent leflunomide

21 January 2018

1 reference

Hepatitis B: the virus and disease

21 January 2018

1 reference

Mycophenolate mofetil and its mechanisms of action

21 January 2018

1 reference

Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activity

21 January 2018

1 reference

A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis.

21 January 2018

1 reference

Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA.

21 January 2018

1 reference

Telbivudine in the treatment of chronic hepatitis B.

21 January 2018

1 reference

Activation and inhibition of cellular calcium and tyrosine kinase signaling pathways identify targets of the HBx protein involved in hepatitis B virus replication

21 January 2018

1 reference

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

21 January 2018

1 reference

Hepatitis B virus capsid particles are assembled from core-protein dimer precursors

21 January 2018

1 reference

Effects of the active metabolite of leflunomide, A77 1726, on cytokine release and the MAPK signalling pathway in human rheumatoid arthritis synoviocytes.

21 January 2018

1 reference

Low dose leflunomide activates PI3K/Akt signalling in erythroleukemia cells and reduces apoptosis induced by anticancer agents.

21 January 2018

1 reference

MAP kinase signalling pathways in cancer

21 January 2018

1 reference

The replication cycle of hepatitis B virus

21 January 2018

1 reference

SB203580, a pharmacological inhibitor of p38 MAP kinase transduction pathway activates ERK and JNK MAP kinases in primary cultures of human hepatocytes.

21 January 2018

1 reference

CPEC induces erythroid differentiation of human myeloid leukemia K562 cells through CTP depletion and p38 MAP kinase

21 January 2018

1 reference

Hepatitis B virus X protein activates the p38 mitogen-activated protein kinase pathway in dedifferentiated hepatocytes

21 January 2018

1 reference

Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein

21 January 2018

1 reference

Characterization of the PC4 binding domain and its interactions with HNF4alpha

21 January 2018

1 reference

Differential regulation of hepatitis B virus gene expression by the Sp1 transcription factor

21 January 2018

1 reference

Role of p38 in stress activation of Sp1.

21 January 2018

1 reference

Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro

21 January 2018

1 reference

Ribavirin and mycophenolic acid markedly potentiate the anti-hepatitis B virus activity of entecavir

21 January 2018

1 reference

The effect of mycophenolate mofetil on hepatitis B viral load in stable renal transplant recipients with chronic hepatitis B.

21 January 2018

1 reference

Mycophenolate mofetil use in hepatitis B associated-membranous and membranoproliferative glomerulonephritis induces viral replication

21 January 2018

1 reference

Precore-mediated inhibition of hepatitis B virus progeny DNA synthesis.

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.25602

1 reference

4 November 2017

1 reference

PubMed ID

22271223